In various mouse models of liver cancer, ARID1A has been shown to exhibit tumor-promoting activity by promoting early transformation, potentially through regulation of oxidative stress pathways mediated by the cytochrome P450 (CYP450) system, which generates reactive oxygen species (ROS). This evidence concerns the gene ARID1A and neoplasm.